Garrett Sato, Director at BIOLASE, INC (BIOL), bought 5,000 shares at $1.07 ($5K) on 2018-12-13, disclosed to the SEC on 2018-12-14.
Open-market purchase of $5k BIOL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |